Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Ritchlin

Showing results (161-170 of 217) with videos related to

Pageof 22
Sort By:
Arthritis Research & Therapy|February 3, 2023
Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg miceH Mark Kenney, Ronald W Wood, Gabriel Ramirez, et al.
The Journal of Rheumatology|May 20, 2008
2007 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)Robert A Colbert, Atul A Deodhar, Muhammad Asim Khan, et al.
The Journal of Rheumatology|February 9, 2018
Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter StudyLihi Eder, Paula Harvey, Vinod Chandran, et al.
ACR Open Rheumatology|March 7, 2023
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 StudiesDennis McGonagle, Iain B McInnes, Atul Deodhar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 25, 2026
Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From the Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept AFFINITY StudyJose U Scher, Iain B McInnes, Enrique R Soriano, et al.
The Journal of Rheumatology|July 17, 2016
Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II StudiesRobin L Thurmond, Andrew Greenspan, Waldemar Radziszewski, et al.
The Journal of Rheumatology|July 9, 2008
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature reviewLaura C Coates, R Rox Anderson, Oliver Fitzgerald, et al.
Arthritis and Rheumatism|June 26, 2008
Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imagingSteven T Proulx, Edmund Kwok, Zhigang You, et al.
The Journal of Rheumatology|November 3, 2005
Outcome measures in psoriatic arthritisDafna D Gladman, Philip J Mease, Gerald Krueger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 11, 2026
Efficacy and Safety of Guselkumab in Participants with Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of the Phase 3, Randomized, Placebo-Controlled SOLSTICE StudyAlexis Ogdie, Joseph F Merola, Philip J Mease, et al.
Pageof 22

Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
Arthritis Research & Therapy|February 3, 2023
Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg miceH Mark Kenney, Ronald W Wood, Gabriel Ramirez, et al.
The Journal of Rheumatology|May 20, 2008
2007 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)Robert A Colbert, Atul A Deodhar, Muhammad Asim Khan, et al.
The Journal of Rheumatology|February 9, 2018
Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter StudyLihi Eder, Paula Harvey, Vinod Chandran, et al.
ACR Open Rheumatology|March 7, 2023
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 StudiesDennis McGonagle, Iain B McInnes, Atul Deodhar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 25, 2026
Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From the Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept AFFINITY StudyJose U Scher, Iain B McInnes, Enrique R Soriano, et al.
The Journal of Rheumatology|July 17, 2016
Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II StudiesRobin L Thurmond, Andrew Greenspan, Waldemar Radziszewski, et al.
The Journal of Rheumatology|July 9, 2008
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature reviewLaura C Coates, R Rox Anderson, Oliver Fitzgerald, et al.
Arthritis and Rheumatism|June 26, 2008
Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imagingSteven T Proulx, Edmund Kwok, Zhigang You, et al.
The Journal of Rheumatology|November 3, 2005
Outcome measures in psoriatic arthritisDafna D Gladman, Philip J Mease, Gerald Krueger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 11, 2026
Efficacy and Safety of Guselkumab in Participants with Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of the Phase 3, Randomized, Placebo-Controlled SOLSTICE StudyAlexis Ogdie, Joseph F Merola, Philip J Mease, et al.
Pageof 22